Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YCT-529 for male contraception in healthy men
NCT06542237Phase 2Recruiting
- Sponsor
- YourChoice Therapeutics
- Start
- Sep 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YCT-529 in male contraception, sponsored by YourChoice Therapeutics. Started Sep 2024; status: recruiting.
02
Drugs
YCT-529
03
Conditions
male contraception
Beyond the preview
Go deeper on NCT06542237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06542237.